|
|
Information on |
|
|
Lotus Pharmaceutical Co., Ltd. |
| Founded in 1966, Lotus is a leading generic company headquartered in Taiwan with comprehensive product portfolio covering CNS, CVS, oncology, women health, and anti-obesity drugs in tablets & hard/softgel capsules. Lotus is actively expanding its businesses in export markets such as US, Japan & China, focusing on high value, difficult-to-make generics. Lotus runs the only plant in Taiwan approved by US FDA, EU EMA, & JP PMDA. In 2014, the fast growing international pharmaceutical Alvogen invested in Lotus via private placement and has thus become its majority shareholder. With Alvogen’s global R&D and commercial infrastructure, Lotus is now well positioned to become top 5 in APAC region. |
|
| Address |
Lotus Pharmaceutical Co., Ltd.
15F, No.149, Sec.3, Xinyi Road
Taipei, Taiwan
|
| Phone |
+886 2 27005908 |
| Fax |
+886 2 27008286 |
| |
send an inquiry |
|
|
|
|
|
|
